All Type of News
False or exaggerated ads of real-estate brokers rampant
There are growing trends that many pharmacists, who desire to newly open or move their pharmacies, have suffered a serious property loss from false or exaggerated advertisements by some real-estate consulting firms.
...
7000 drugs to delist from NHI reimbursement schedule
The drugs of no completing the efficacy equivalent tests until the end of April seem to be ousted from the NHI reimbursement schedule as planned, the MOHW said on March 7.
The MOHW also said that the above plan wo...
Drug wholesalers and Zuellig to seek coexistence.
Breathlessly ensuing serial counter measures and frustrations against Zuellig issue through a declaration of business termination and a lawsuit for loss compensation etc., Youngnam provincial pharmaceutical wholesaler...
Pharmaceutical industry being strongly opposed to submission of any trade secrets
Business sources say that many pharmaceutical firms have decided not to submit to the Ministry of Health and Welfare (MOHW) any cost breakdown related data of locally manufactured or imported drugs for the protection ...
KFDA eyes more strengthened pharmaceutical affairs inspection
The Korea Food and Drug Administration has announced that it will make a nationwide inspection on some popular ethical drugs sold without doctor's prescriptions (e.g., Xenical, Viagra, Norlevo, etc) at the medical ins...
News on human embryonic cloning permission found untrue.
The Ministry of Science and Technology (MOST) clarified the recent news as a rootless rumor on March 6 that the government already approved the human embryonic cloning research. The Ministry further made it clear that...
(Focus news) Zuellig and Wholesale community now under introspection.
The compensation suit for business losses raised by Zuellig against Dongwon in the amount of 4.8 billion won has been settled down, and the Youngnam provincial association of the KPhWA concluded in the monthly meeting...
5% reduction of insurance-covered drug price improbable
The Ministry of Health and Welfare says that the reduction of insurance-covered price by a level of 5 percent was not be discussed or determined, although this issue was raised by some previous meetings.
The MOHW ...
Pharmaceutical firms hesitant to sponsor scientific meetings
Business industry sources say that the recent revision of fair competition code emphasizing more tight control on the sponsorship of scientific meetings at home and abroad is bothering many domestic pharmaceutical fir...
Jeil Pharm and Cheil Jedang to jointly develop anti-diabetic drug
Jeil Pharm says that in parallel with the government's landmark long-term plan to actively promote the bioengineering technology industry on a continual basis, it will initiate a large-scale R&D new drug project to de...
